By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Generation Health has contracted with PGXL Laboratories to be a preferred genetic testing lab providing molecular diagnostic test services for Generation Health.

In a pilot program starting next month, the partners will provide pharmacogenetic testing and diagnostic services to a limited number of patients through healthcare providers. In January 2011, those services will be opened up to all GH patients, Brad Esarey, director of sales and marketing for PGXL, said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.